Enhanced external counterpulsation increases coronary flow reserve in coronary microvascular disease

References

1. 1.↵
   1. Ford TJ,
   2. Stanley B,
   3. Good R,
   4. Rocchiccioli P,
   5. McEntegart M,
   6. Watkins S, et al.

   Stratified medical therapy using invasive coronary function testing in angina: The CorMicA trial. J Am Coll Cardiol 2018; 72: 2841-2855.

   OpenUrlFREE Full Text
2. 2.
   1. Sara JD,
   2. Widmer RJ,
   3. Matsuzawa Y,
   4. Lennon RJ,
   5. Lerman LO,
   6. Lerman A.

   Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv 2015; 8 :1445-1453.

   OpenUrlAbstract/FREE Full Text
3. 3.
   1. Taqueti VR,
   2. Solomon SD,
   3. Shah AM,
   4. Desai AS,
   5. Groarke JD,
   6. Osborne MT, et al.

   Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 2018;39: 840-849.

   OpenUrlCrossRefPubMed
4. 4.
   1. Jürs A,
   2. Pedersen LR,
   3. Olsen RH,
   4. Snoer M,
   5. Chabanova E,
   6. Haugaard SB, et al.

   Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease. BMC Cardiovasc Disord 2015; 15: 159.

   OpenUrl
5. 5.↵
   1. Taqueti VR,
   2. Di Carli MF.

   Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol 2018; 72: 2625-2641.

   OpenUrlFREE Full Text
6. 6.↵
   1. Bradley C,
   2. Berry C.

   Definition and epidemiology of coronary microvascular disease. J Nucl Cardiol. 2022;29(4):1763-1775.

   OpenUrl
7. 7.↵
   1. Chen C,
   2. Wei J,
   3. AlBadri A,
   4. Zarrini P,
   5. Bairey Merz CN.

   Coronary microvascular dysfunction—epidemiology, pathogenesis, prognosis, diagnosis, risk factor, and therapy. Circ J 2016; 81: 3–11.

   OpenUrlCrossRef
8. 8.↵
   1. Sinha A,
   2. Rahman H,
   3. Pereracorresponding D.

   Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management. Cardiovasc Endocrinol Metab 2020; 10: 22-30.

   OpenUrl
9. 9.↵
   1. Qin X,
   2. Deng Y,
   3. Wu D,
   4. Yu L,
   5. Huang R.

   Does enhanced external counterpulsation (EECP) significantly affect myocardial perfusion? A systematic review & meta-analysis. PLoS One 2016; 11: e0151822.

   OpenUrl
10. 10.↵
    1. Lawton JS,
    2. Tamis-Holland JE,
    3. Bangalore S,
    4. Bates ER,
    5. Beckie TM,
    6. Bischoff JM, et al.

    2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2022; 145: e4-e17.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Ford TJ,
    2. Ong P,
    3. Sechtem U,
    4. Beltrame J,
    5. Camici PG,
    6. Crea F, et al.

    Assessment of vascular dysfunction in patients without obstructive coronary artery disease: Why, how, and when. JACC Cardiovasc Interv 2020; 13: 1847-1864

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Tagliamonte E,
    2. Cirillo T,
    3. Rigo F,
    4. Astarita C,
    5. Coppola A,
    6. Romano C, et al.

    Ivabradine and bisoprolol on doppler-derived coronary flow velocity reserve in patients with stable coronary artery disease: Beyond the heart rate. Adv Ther 2015; 32: 757-767.

    OpenUrl
13. 13.↵
    1. Yang H,
    2. Song L,
    3. Ning X,
    4. Ma Y,
    5. Xue A,
    6. Zhao H,
    7. Du Y,
    8. Lu Q,
    9. Liu Z,
    10. Wang J.

    Enhanced external counterpulsation ameliorates endothelial dysfunction and elevates exercise tolerance in patients with coronary artery disease. Front Cardiovasc Med 2022; 9: 997109.

    OpenUrl
14. 14.↵
    1. Zhang Y,
    2. Chen Z,
    3. Mai Z,
    4. Zhou W,
    5. Wang H,
    6. Zhang X, et al.

    Acute hemodynamic responses to enhanced external counterpulsation in patients with coronary artery disease. Front Cardiovasc Med 2021; 8: 721140.

    OpenUrl
15. 15.↵
    1. Jan R,
    2. Khan A,
    3. Zahid S,
    4. Sami A,
    5. Owais SM,
    6. Khan F,
    7. Asjad SJ,
    8. Jan MH,
    9. Awan ZA.

    The Effect of Enhanced External Counterpulsation (EECP) on quality of life in patient with coronary artery disease not amenable to PCI or CABG. Cureus 2020; 12: e7987.

    OpenUrl
16. 16.↵
    1. Du F,
    2. Zhang W,
    3. Mao H,
    4. Guo Y,
    5. Guo M,
    6. Lu Y,
    7. Chen M,
    8. Sha Z.

    The Effect of long-term external counterpulsation combined with exercise therapy on the establishment of collateral circulation in patients with coronary artery occlusive disease. Biomed Res Int 2022; 2022: 1336184.

    OpenUrl
17. 17.↵
    1. Ong P,
    2. Camici PG,
    3. Beltrame JF,
    4. Crea F,
    5. Shimokawa H,
    6. Sechtem U, et al.

    International standardization of diagnostic criteria for microvascular angina. Int J Cardiol 2018; 250: 16-20.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Thakker RA,
    2. Rodriguez Lozano J,
    3. Rodriguez Lozano P,
    4. Motiwala A,
    5. Rangasetty U,
    6. Khalife W, et al.

    Coronary microvascular disease. Cardiol Ther 2022; 11: 23-31.

    OpenUrl